Discontinuation and dose reduction of rituximab in relapsing-remitting multiple sclerosis. Boremalm M, Sundstrom P, Salzer J. J Neurol 2021 Jan 21. pii: 10.1007/s00415-021-10399.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Boremalm M, Sundstrom P, Salzer J. Discontinuation and dose reduction of rituximab in relapsing-remitting multiple sclerosis. J Neurol 2021 Jan 21. pii: 10.1007/s00415-021-10399.
PMID: 33475825